21247 Results

People

  1. Brennan
    Brennan
  2. Jarnagin
    Jarnagin
  3. Abu-Rustum
    Abu-Rustum
  4. Rusch
    Rusch
  5. D'Angelica
    D'Angelica
  6. Fong
    Fong
  7. Morrow
    Morrow
  8. Shah
    Shah
  9. Chi
    Chi
  10. Shaha
    Shaha

Groups

  1. Surgery (21247)
  2. Survivorship Research (5130)
  3. Department of Medicine (4873)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4018)
  6. Epidemiology and Biostatistics (3680)
  7. Department of Pathology and Laboratory Medicine (3639)
  8. Center for Pancreatic Cancer Research (3115)
  9. Population Sciences Research Program (2966)
  10. GSK Faculty (2773)
  1. "Surgery"
Formats
  1. Journal Article (13274)
  2. Meeting Abstract (4871)
  3. Book Section (1145)
  4. Review (581)
  5. Editorial (559)
  6. Conference Paper (249)
  7. Correspondence (151)
  8. Miscellaneous (141)
  9. Guidelines (125)
  10. Book Whole (91)
  11. Research Letter (60)
Groups
  1. Surgery (21247)
  2. Survivorship Research (5130)
  3. Department of Medicine (4873)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4018)
  6. Epidemiology and Biostatistics (3680)

More Groups

People
  1. Murray Brennan (1059)
  2. William Jarnagin (903)
  3. Nadeem Abu-Rustum (888)
  4. Valerie Rusch (864)
  5. Michael D'Angelica (777)
  6. Yuman Fong (775)

More People

Years
  1. 2025 (375)
  2. 2024 (984)
  3. 2023 (930)
  4. 2022 (1036)
  5. 2021 (954)
  6. 2020 (919)

More Years

Publications
  1. Journal of Clinical Oncology (1551)
  2. Annals of Surgical Oncology (1512)
  3. Gynecologic Oncology (874)
  4. Journal of Urology (548)
  5. International Journal of Radiation Oncology, Biology, Physics (458)
  6. Cancer (424)

More Publications

Publishers
  1. Elsevier Inc. (3546)
  2. Springer (2678)
  3. Elsevier Science, Inc. (2049)
  4. Lippincott Williams & Wilkins (1663)
  5. American Society of Clinical Oncology (1644)
  6. Wiley Blackwell (1224)

More Publishers

Results (21247)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
    Journal Article

    Golkaram, M.; Kuo, F.; Gupta, S.; Carlo, M. I.; Salmans, M. L.; Vijayaraghavan, R.; Tang, C.; Makarov, V.; Rappold, P.; Blum, K. A.; more...
    Genome Medicine (2022)

    Fulltext@MSK | Save
  • Next-generation immunotherapy for solid tumors: Combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1
    Review

    Quach, H. T.; Hou, Z.; Bellis, R. Y.; Saini, J. K.; Amador-Molina, A.; Adusumilli, P. S.; Xiong, Y.
    Expert Opinion on Investigational Drugs (2022)

    Fulltext@MSK | Save
  • Associations between pretreatment body composition features and clinical outcomes among patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint blockade
    Journal Article

    Ged, Y.; Sanchez, A.; Patil, S.; Knezevic, A.; Stein, E.; Petruzella, S.; Weiss, K.; Duzgol, C.; Chaim, J.; Akin, O.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention
    Journal Article

    Giraldo, N. A.; Drill, E.; Satravada, B. A.; El Dika, I.; Brannon, A. R.; Dermawan, J.; Mohanty, A.; Ozcan, K.; Chakravarty, D.; Benayed, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • An immunocompetent rectal cancer model to study radiation therapy
    Journal Article

    Kim, J. K.; Wu, C.; Del Latto, M.; Gao, Y.; Choi, S. H.; Kierstead, M.; Gabriel Sauvé, C. E.; Firat, C.; Perez, A. C.; Sillanpaa, J.; more...
    Cell Reports Methods (2022)

    Fulltext@MSK | Save
  • Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
    Journal Article

    Clinton, T. N.; Chen, Z.; Wise, H.; Lenis, A. T.; Chavan, S.; Donoghue, M. T. A.; Almassi, N.; Chu, C. E.; Dason, S.; Rao, P.; more...
    Cell Reports (2022)

    Fulltext@MSK | Save
  • Association of prostate-specific antigen levels with prostate cancer risk in a multiethnic population: Stability over time and comparison with polygenic risk score
    Journal Article

    Chou, A.; Darst, B. F.; Wilkens, L. R.; Marchand, L. L.; Lilja, H.; Conti, D. V.; Haiman, C. A.
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • Cell-free RB1 DNA not detected in the blood of pseudoretinoblastoma patients
    Journal Article

    Abramson, D. H.; Mandelker, D.; Brannon, A. R.; Berger, M. F.; Robbins, M.; Dunkel, I. J.; Francis, J. H.
    BMJ Open Ophthalmology (2022)

    Fulltext@MSK | Save
  • Comparing the effects of neoadjuvant versus adjuvant chemotherapy in stage II-III, triple-negative breast cancer: Illustration of trial emulation using the clone-censor-weight method
    Meeting Abstract

    Su, I. H.; Gaber, C.; Downs-Canner, S.; Duchesneau, E.; Lund, J.
    Pharmacoepidemiology and Drug Safety (2022)

    Fulltext@MSK | Save
  • An immunohistochemistry panel is a useful tool for identifying retinoblastoma molecular subtypes
    Meeting Abstract

    Aschero, R.; Lamas, G.; Restrepo, C.; Francis, J.; Vilanova, M. C.; Grigorovski, N.; Dufort, G.; Nespoli, E.; Barriga, P.; Schaiquevich, P.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save